WG
IBIO icon

Winton Group’s iBio IBIO Stock Holding History

Winton Group’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-155
Closed -$117K – 1400
2021
Q2 		$117K Sell
155
-53
-25% -$38.7K 0.01% 1380
2021
Q1 		$160K Buy
208
+174
+512% +$152K 0.01% 1305
2020
Q4 		$18K Sell
34
-28
-45% -$22.8K ﹤0.01% 1298
2020
Q3 		$63K Buy
62
+17
+38% +$24.6K ﹤0.01% 1433
2020
Q2 		$50K Buy
+45
New +$29.4K ﹤0.01% 1417

Other funds holding IBIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Winton Group's IBIO Position: Q3 2021 in Review

Winton Group sold out of iBio (IBIO) in Q3 2021, closing a stake of 155 shares — an estimated $117K sold.

Winton Group first reported a position in IBIO in Q2 2020 and held it in 5 quarters. The position peaked at $160K in Q1 2021. 85 funds tracked by Wall St. Rank hold IBIO as of Q3 2021.

  • Winton Group reported no remaining iBio position as of Q3 2021 after selling out during the quarter.
  • Winton Group sold 155 iBio shares in Q3 2021, an estimated $117K.
  • Winton Group first reported a position in iBio in Q2 2020 and held it in 5 quarters.
  • Winton Group's iBio position peaked at $160K in Q1 2021.
  • 85 funds tracked by Wall St. Rank held iBio as of Q3 2021.

Based on Winton Group's 13F filing for Q3 2021, filed 28 Oct 2021.